[Activated protein C, coagulation, inflammation and treatment of severe sepsis].
Bartelink
A K
AK
van Deuren
M
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D009426:Netherlands; D018579:Patient Selection; D011486:Protein C / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D011994:Recombinant Proteins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy* / Q000378:metabolism; D014481:United States
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D011486:Protein C; D011994:Recombinant Proteins